Sign in|Join Now|Feedback
Tuesday, February 14, 2012
Advertisement

News: February 14, 2012

Besivance Approved for Bacterial Conjunctivitis
FRIDAY, May 29 (HealthDay News) -- Besivance (besifloxacin ophthalmic suspension 0.6 percent) has been approved by the U.S. Food and Drug Administration to treat bacterial conjunctivitis, often dubbed "pink eye." The contagious infection is charac...
Healthline Tools
3D Body Maps
Advertisement
Healthline : Connect to Better Health

Follow on Twitter Follow on Facebook
More:
Site Map
MyHealthline
Health Directories:
Health and Wellness A to Z
Health Blogs A to Z
Diseases A to Z
Learning Centers A to Z
Drugs A to Z
Drugs by Disease
Supplements A to Z
Supplements by Disease
Symptoms A to Z
Symptoms by Disease
Slideshows A to Z
Videos A to Z
Videos by Disease
Company Info:
About Us
Healthline.com Staff
News and Events
Advertise
Careers
Contact
Customer Care
Help
Terms of Use
Privacy Policy
Copyright © 2005 - 2012 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details